Most active investors · Jul 19, 2026 – Oct 16, 2026
Ranked by rounds participated in, from announcements in Jul 19, 2026 – Oct 16, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
XBE Undisclosed GrowthHorizon3 $250M Series EDetails
Details
New companies 2 · Follow-on 0
Stages: Series C+ 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Leal Therapeutics $30M Series AKhartis Therapeutics $50M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
SweGaN $14M Series BMindgard $30M Series ADetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Birdsview NOK 40.5M Funding roundVisoid $2.5M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Wispr Flow $280M Series BNatural $30M Series ADetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Gallos Technologies $50M GrowthMoa Technology £22.2M Series CDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Wispr Flow $280M Series BLumilens >$700M Series CDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series A 1
Gravis Robotics $200M Series AThrive Holdings $2B GrowthDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Khartis Therapeutics $50M Series BInfinimmune $75M Series ADetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Databricks $5B GrowthCandid Health $120M Series DDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series A 1
Thrive Holdings $2B GrowthVolta $300M Series ADetails
New companies 1 · Follow-on 1
Stages: Seed 1, Series B 1
Heaviside Industries $60M Series BSoctera $4M SeedDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Thrive Holdings $2B GrowthBase Power $1B Series DDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
CodeRabbit $143M Series CUniti $12M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 2
Beyang Therapeutics $30M Series ACORE Biomedicine $21M Series ADetails
New companies 2 · Follow-on 0
Stages: Pre-seed 2
Zerolook CHF 1.5M Pre-seedExclaim Robotics $5M Pre-seedDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Natural $30M Series AAmbrook $30M Series BDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Epicrispr Biotechnologies $90M Series CCrystalys Therapeutics $130M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 2
Epicrispr Biotechnologies $90M Series CRatio Therapeutics $70M Series CDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Discovered Materials $9M SeedMitti Labs $9.5M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Flagler Health $50M Series BThrone Science $10M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Plinq R$1.3M First funding roundPaper $34M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Naked Energy £8.9M Series B extensionAdvanced Electric Machines Group £16M Funding round“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.